Pharmadax Inc (法德生技藥品) yesterday said it has gained marketing approval in China for its generic schizophrenia drug and expects to grab 20 percent of the market within three years.
On Sunday, the company received approval from the Chinese National Medical Products Administration (NMPA) for the 50mg, 150mg, 200mg, 300mg and 400mg versions of its quetiapine fumarate ER tablets, Pharmadax said, adding that its drug is the generic version of AstraZeneca PLC’s Seroquel XR tablet.
The company obtained US Food and Drug Administration (FDA) approval for the antipsychotic drug in 2017.
The US approval helped the firm secure a priority review with the NMPA, which sped up the licensing process to less than two years, Pharmadax said.
While competition has become heated in the US, with a few companies producing generic versions of Seroquel, including Handa Pharmaceuticals Inc (漢達生技) and India’s Lupin Ltd, Pharmadax said that there would be less competition in China.
“Currently, only the original Seroquel is available in China, and we are the first generic drug company to obtain approval, while other companies are still waiting, so we are confident that we can stay ahead of our rivals,” a company official told the Taipei Times.
Sales of quetiapine fumarate tablets in China increased 32.13 percent year-on-year to 1.75 billion yuan (US$244.9 million) last year, Pharmadax said.
With the Chinese government paying more attention to mental health, more health programs or support services are expected to be launched in the country, which would likely boost sales of antipsychotic drugs, the company said.
Pharmadax has set a target of annual sales growth of 50 percent over the next three years, aided by China-based Coland Holdings Ltd (康聯控股), which is responsible for marketing the drug for the next five years.
Coland has set up distribution channels in more than 200 cities and at more than 3,500 hospitals in China, Pharmadax said.
The company said it would begin marketing the drug in China soon, declining to give an exact date.
Pharmadax has finalized the prices for Quetiapine Fumarate with Coland, which would be slightly lower than the original drug, it said.
The company would produce 800 million tablets per year at its two plants in Foshan, Guangdong Province, it added.
SEEKING CLARITY: Washington should not adopt measures that create uncertainties for ‘existing semiconductor investments,’ TSMC said referring to its US$165 billion in the US Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) told the US that any future tariffs on Taiwanese semiconductors could reduce demand for chips and derail its pledge to increase its investment in Arizona. “New import restrictions could jeopardize current US leadership in the competitive technology industry and create uncertainties for many committed semiconductor capital projects in the US, including TSMC Arizona’s significant investment plan in Phoenix,” the chipmaker wrote in a letter to the US Department of Commerce. TSMC issued the warning in response to a solicitation for comments by the department on a possible tariff on semiconductor imports by US President Donald Trump’s
‘FAILED EXPORT CONTROLS’: Jensen Huang said that Washington should maximize the speed of AI diffusion, because not doing so would give competitors an advantage Nvidia Corp cofounder and chief executive officer Jensen Huang (黃仁勳) yesterday criticized the US government’s restrictions on exports of artificial intelligence (AI) chips to China, saying that the policy was a failure and would only spur China to accelerate AI development. The export controls gave China the spirit, motivation and government support to accelerate AI development, Huang told reporters at the Computex trade show in Taipei. The competition in China is already intense, given its strong software capabilities, extensive technology ecosystems and work efficiency, he said. “All in all, the export controls were a failure. The facts would suggest it,” he said. “The US
The government has launched a three-pronged strategy to attract local and international talent, aiming to position Taiwan as a new global hub following Nvidia Corp’s announcement that it has chosen Taipei as the site of its Taiwan headquarters. Nvidia cofounder and CEO Jensen Huang (黃仁勳) on Monday last week announced during his keynote speech at the Computex trade show in Taipei that the Nvidia Constellation, the company’s planned Taiwan headquarters, would be located in the Beitou-Shilin Technology Park (北投士林科技園區) in Taipei. Huang’s decision to establish a base in Taiwan is “primarily due to Taiwan’s talent pool and its strength in the semiconductor
French President Emmanuel Macron has expressed gratitude to Hon Hai Precision Industry Co (鴻海精密) for its plan to invest approximately 250 million euros (US$278 million) in a joint venture in France focused on the semiconductor and space industries. On his official X account on Tuesday, Macron thanked Hon Hai, also known globally as Foxconn Technology Group (富士康科技集團), for its investment projects announced at Choose France, a flagship economic summit held on Monday to attract foreign investment. In the post, Macron included a GIF displaying the national flag of the Republic of China (Taiwan), as he did for other foreign investors, including China-based
RSS